ANDROGENMODULATOREN

Patent europeic · EP1789408 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1789408
Numer da la dumonda
EP05779469
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
22-08-2005
Publitgà
30-05-2007
Concedì
16-04-2008
Stritgà
31-08-2009
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 307/32 (2006.01)
A61P 5/28 (2006.01)
A61K 31/341 (2006.01)
Prioritad
US 605896 P 31.08.2004
Dumonda PCT
PCT/IB2005/002700 22.08.2005
Publicaziun PCT
WO2006/024942 09.03.2006
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 17-03-2010

    Stritgà, taxa betg pajada

    Published in Swissreg on 17.03.2010

  2. 15-05-2008

    Concedì

    Published in +pat+ No 9 in 2008

Partidas

Inventur

BARRETT, Stephen Douglas, Pfizer Global R & D

Ann Arbor, MI 48105, US

DU, Daniel Yunlong, Pfizer Global R & D

Ann Arbor, MI 48105, US

HU, Lain-Yen, Pfizer Global R & D

Ann Arbor, MI48105, US

LEFKER, Bruce Allen, Pfizer Global R & D

Groton, CT 06340, US

RAHEJA, Raj Kumar, Pfizer Global R & D

Ann Arbor, MI 48105, US

SEXTON, Karen Elaine, Pfizer Global R & D

Ann Arbor, MI 48105, US

SMITH, Yvonne Dorothy, Pfizer Global R & D

Ann Arbor, MI 48105, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.